Genome Organization in E. Coli
Genome Organization in E. Coli
Genome Organization in E. Coli
coli
• Although bacteria do not have histones, they possess a group of DNA binding
proteins referred to as nucleoid-associated proteins (NAPs) that are
functionally analogous to histones in a broad sense. NAPs are highly abundant
and constitute a significant proportion of the protein component of the
nucleoid. A distinctive characteristic of NAPs is their ability to bind DNA in both
a specific (either sequence- or structure-specific) and non-sequence specific
manner. As a result, NAPs are dual function proteins.
• There are at least 12 NAPs identified in E. coli, the most extensively studied
NAPs are HU, IHF, H-NS, and Fis.
•
A. The circular layout of the E. coli genome (as shown in Fig 1A) additionally depicting the
genome occupancy of indicated NAPs in the growth phase. B. The genome occupancy of
indicated NAPs in the stationary phase. The genome layout is the same as in A. The genome
occupancy of each NAP, determined by ChIP-Seq, is plotted as a histogram (bin size 300 bp)
in which the bar height is indicative of relative binding enrichment.
The “100 min” map of E. coli genome
• The “100 minute map” is a time-based map of the E. coli genome. Based on
the assumption/observation that it takes 100 minutes to replicate the
genome, the map is a listing of at what points in time a particular gene is
copied; in this case, it is
looking at clusters of genes (it is important to note that most genes are not
clustered).
Applications
• Plays an important role in genetic engineering and industrial microbiology. Researchers can
introduce genes into microbes using plasmids which permit high level expression of protein, and
such proteins maybe mass produced in industrial fermentation process.
• Plasmids and restriction enzymes used to create recombinant DNA in E. coli was the basis of
biotechnology. Due to the low cost and speed with which it can be grown and modified in laboratory
settings. E. coli is a popular expression platform for production of the recombinant proteins used in
therapeutics.
REFERENCES
1. Russell, P. J. (2010). iGenetics: A molecular approach. 3rd edition. San Francisco:
Benjamin Cummings
2. Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, et al. The complete
genome sequence of Escherichia coli K-12. Science. 1997 Sep 5; 277(5331): 1453–
62.
3. Griswold, A. (2008) Genome packaging in prokaryotes: the circular chromosome of E.
coli.
Nature Education 1(1):57
4. Verma SC, Qian Z, Adhya SL (2019) Architecture of the Escherichia coli
nucleoid. PLOS Genetics 15(12): e1008456.
https://doi.org/10.1371/journal.pgen.1008456